The Goldman Sachs Group Has Lowered Expectations for Teladoc Health (NYSE:TDOC) Stock Price

Teladoc Health (NYSE:TDOCGet Free Report) had its target price decreased by research analysts at The Goldman Sachs Group from $16.00 to $13.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the health services provider’s stock. The Goldman Sachs Group’s price target indicates a potential upside of 32.48% from the stock’s current price.

Other research analysts have also issued research reports about the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a report on Thursday. Bank of America raised their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a report on Wednesday, February 12th. Royal Bank of Canada lifted their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Piper Sandler cut their target price on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday. Finally, Oppenheimer decreased their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Eleven investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $11.26.

Check Out Our Latest Report on Teladoc Health

Teladoc Health Stock Performance

Shares of TDOC traded up $0.25 during mid-day trading on Monday, hitting $9.81. 1,981,628 shares of the company traded hands, compared to its average volume of 8,210,544. The stock has a market cap of $1.69 billion, a price-to-earnings ratio of -1.70 and a beta of 1.05. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The stock has a 50-day moving average price of $10.62 and a two-hundred day moving average price of $9.59. Teladoc Health has a 1 year low of $6.76 and a 1 year high of $15.95.

Teladoc Health (NYSE:TDOCGet Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. Equities analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current year.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TDOC. Versant Capital Management Inc lifted its holdings in shares of Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after acquiring an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC purchased a new position in Teladoc Health in the fourth quarter valued at $29,000. Lindbrook Capital LLC raised its position in Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock valued at $33,000 after purchasing an additional 1,612 shares in the last quarter. Sterling Capital Management LLC grew its position in shares of Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock worth $42,000 after buying an additional 4,101 shares in the last quarter. Finally, Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Teladoc Health during the fourth quarter worth approximately $60,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

See Also

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.